A comparison between the Intercept Oral Fluid Collection Device® and urinalysis among Baltimore City probationers{star, open}1The current study was funded by OraSure Technologies, Inc., in Bethlehem, Pennsylvania (www.orasure.com).

Journal of Criminal Justice

Volumn 34, Issue 4, 2006, Pages 413-424

  Yacoubian Jr , George S ^a   Cone, Edward J ^b  

^a PACIFIC INSTITUTE FOR RESEARCH AND EVALUATION   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33748413022     PISSN: 00472352     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrimjus.2006.05.007     Document Type: Article

References (26)

1. Arria A., Yacoubian G., Fost E., and Wish E.D. Ecstasy use among club rave attendees. Archives of Pediatrics and Adolescent Medicine 156 (2002) 295-296
2. Barrett C., Good C., and Moore C. Comparison of point-of-collection screening of drugs of abuse in oral fluid with a laboratory-based urine screen. Forensic Science International 122 (2001) 163-166
3. Cone E.J. Saliva testing for drugs of abuse. In: Malamud D., and Tabak L. (Eds). Saliva as a diagnostic fluid (1993), New York Academy of Sciences, New York 86-127
4. Cone E.J. New developments in biological measures of drug prevalence. In: Harrison L., and Hughes A. (Eds). The validity of self-reported drug use: Improving the accuracy of survey estimates (1997), U.S. Department of Health and Human Services, Rockville, MD 108-129
5. Huestis M.A., Mitchell J.M., and Cone E.J. Lowering the federally mandated cannabinoid immunoassay cutoff increases true-positive results. Clinical Chemistry 40 (1994) 729-733
6. Johnston L.D., O'Malley P.M., and Bachman J.G. Monitoring the future: A continuing study of American youth (12th grade survey), 2002 (2003), Institute for Social Research, Ann Arbor, MI
7. Lilienfield D.E., Stolley P.D., and Lilienfield A.M. Foundations of epidemiology (1994), Oxford University Press, New York
8. Magura S., and Kang S. Validity of self-reported drug use in high-risk populations: A meta-analytical review. Substance Abuse and Misuse 31 (1996) 1131-1153
9. Mieczkowski T. Drug testing technology: Assessment of field applications (1999), CRC Press, Boca Raton, FL
10. Mieczkowski T., and Lersch K. Drug testing in criminal justice. National Institute of Journal 1997 (1997) 9-15
11. Moore L., Wicks J., Spiehler V., and Holgate R. Gas chromatography-mass spectrometry confirmation of Cozart RapiScan saliva methadone and opiate tests. Journal of Analytical Toxicology 25 (2001) 520-524
12. National Institute of Justice. 1998 Arrestee Drug Abuse Monitoring (ADAM) annual report (1999), U.S. Department of Justice, Washington, DC
13. National Institute of Justice. 2000 Arrestee Drug Abuse Monitoring annual report (2003), U.S. Department of Justice, Washington, DC
14. Niedbala R.S., Kardos K., Fries T., Cannon A., and Davis A. Immunoassay for detection of cocaine/metabolites in oral fluids. Journal of Analytical Toxicology 25 (2001) 62-68
15. Niedbala R.S., Kardos K., Fritch D., Kardos S., Fries T., Waga J., et al. Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana. Journal of Analytical Toxicology 25 (2001) 310-315
16. Niedbala R.S., Kardos K., Waga J., Fritch D., Yeager L., Doddamane S., et al. Laboratory analysis of remotely collected oral fluid specimens by immunoassay. Journal of Analytical Toxicology 25 (2001) 310-315
17. Speckl I.M., Hallbach J., Guder W.G., Meyer L., and Zilker T. Opiate detection in saliva and urine-A prospective comparison by gas chromatography-mass spectrometry. Clinical Toxicology 37 4 (1999) 441-445
18. Substance Abuse and Mental Health Services Administration. Proposed revisions to mandatory guidelines for federal workplace drug testing programs. Federal Register 69 71 (2004, April 13) 19673-19732
19. Wish E.D., and Yacoubian G. Findings from the 2001 Baltimore City Substance Abuse Need for Treatment among Arrestees (SANTA) project (2001), Center for Substance Abuse Research, College Park, MD
20. Wish E.D., and Yacoubian G. A comparison of the Intercept Oral Specimen Collection Device® to laboratory urinalysis among Baltimore City arrestees. Federal Probation 66 1 (2002) 27-29
21. Yacoubian G. The sins of ADAM: Toward a new national criminal justice drug use surveillance system. International Journal of Drug Testing 3 (2004). http://www.criminology.fsu.edu/journal/volume3.html Retrieved from: http://www.criminology.fsu.edu/journal/volume3.html
22. Yacoubian G., Boyle C.L., Harding C.A., and Loftus E.A. It's a rave new world: Estimating the prevalence and perceived harm of ecstasy and other drugs among club rave attendees. Journal of Drug Education 33 2 (2003) 187-196
23. Yacoubian G., Deutsch J., and Schumacher E. Estimating the prevalence of ecstasy use among club rave attendees. Contemporary Drug Problems 31 (2004) 163-177
24. Yacoubian G., and Peters R. Exploring the prevalence and correlates of methamphetamine use: Findings from Sacramento's ADAM program. Journal of Drug Education 34 3 (2004) 281-294
25. Yacoubian G., and Wish E.D. A comparison of oral fluid analysis to laboratory urinalysis among Baltimore City treatment clients. International Journal of Drug Testing 3 (2004). http://www.criminology.fsu.edu/journal/volume3.html Retrieved from: http://www.criminology.fsu.edu/journal/volume3.html
26. Yacoubian G., Wish E.D., and Pérez D.M. A comparison of saliva testing to urinalysis in an arrestee population. Journal of Psychoactive Drugs 33 (2001) 289-294